@FierceMedDev: Claret Medical ropes in $18M to develop cerebral protection system for TAVR procedures. ICYMI yesterday | Follow @FierceMedDev
@VarunSaxena2: UPDATED with table of deadlines: FDA clarifies UDI requirements with new guidance. Story | Follow @VarunSaxena2
@EmilyWFierce: Pruning of synapses in brain could provide clues to how autism develops in children, say scientists. More from the NYT | Follow @EmilyWFierce
> Saranas, a Houston-based startup, is building a device to detect internal bleeding resulting from vascular-access procedures. About 5% of the 20 million patients annually can be affected by accidental punctures. More
> Second Sight Medical's Argus II vision system will be used to treat 36 patients funded by the French Ministry of Health. The retinal implant company recently filed for a $32 million IPO to fund its camera-based product that restores sight for some blind patients. Read
> Advanced Cooling Therapy closed a Series A funding of $1.5M to support the launch of its Esophageal, the first product from the Chicago-based company. Release
> Large corporations are attempting to save on medical insurance costs by encouraging employees to wear fitness-tracking devices. Companies including BP, UnitedHealth Group, Humana and others offer rewards to employees who show healthy habits through data collected by the trackers. Story
Biotech News
@FierceBiotech: Low levels of enzyme in Alzheimer's brains suggest new drug target. More from FierceBiotech Research | Follow @FierceBiotech
@JohnCFierce: ICYMI yesterday: J&J, AstraZeneca and Sanofi join Illumina to create a pan-cancer test. Report | Follow @JohnCFierce
@DamianFierce: A glimpse at the glamorous hedonism that runs rampant in Big Pharma. Image | Follow @DamianFierce
@EmilyMFierce: Parents more likely to vaccinate kids against measles when child's, not society's, benefits are stressed. FierceVaccines story | Follow @EmilyMFierce
> Pfizer-AstraZeneca sequel could hit theaters next week. Article
> Cubist nears another big antibiotic approval as M&A rumors simmer. Story
> Israel's NeuroDerm banks $16M to advance its Parkinson's pump. More
Pharma News
@FiercePharma: Top-read news in FP Thurs: Pfizer eyes Actavis in backup plan to another AstraZeneca bid. Article | Follow @FiercePharma
@TracyStaton: ICYMI this week: @NovoNordisk CEO on the house that Victoza built and the future of diabetes R&D. Report | Follow @TracyStaton
@EricPFierce: DEA tightens prescribing, limits refills on opioid combo pills like #Vicodin. Story | Follow @EricPFierce
@CarlyHFierce: ICYMI earlier - Report: Takeda's dengue jab will be nipping at Sanofi's heels by 2020. Article | Follow @CarlyHFierce
> 2014 has potential to exceed milestone year of 2009 for M&A action. News
> Pfizer, BMS pad bright Q2 with new FDA nod for Eliquis. More
> DEA tightens opioid dispensing rules amid controversy over abuse. Story